THE EHLERS DANLOS SOCIETY
LIVE

Serial Number

97516490

Owner

The Ehlers-Danlos Society

Attorney

Jeffrey H. Greger

Filing Date

Jul 22, 2022

Add to watchlist:

No watchlists yet
View on USPTO

THE EHLERS DANLOS SOCIETY Trademark

Serial Number: 97516490 • Registration: 7505027

THE EHLERS DANLOS SOCIETY is a trademark filed by The Ehlers-Danlos Society on July 22, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

The Ehlers-Danlos Society

Office 7
London EC4M7JN , GB

Entity Type: 03

Trademark Details

Filing Date

July 22, 2022

Registration Date

September 17, 2024

Published for Opposition

July 2, 2024

Goods & Services

Medical support services in the nature of providing a website featuring information in the field of genetic connective tissue disorders; the provision of medical advice in the field of medicine, pharmaceuticals, medical treatments, health, disease and genetic disorders; the provision of medical advice in the field of medicine, pharmaceuticals, medical treatments, health, disease and genetic disorders via medical advice helplines; providing medical support in the nature of providing information to patients with genetic connective tissue disorders; providing medical information in the field of treatments for genetic disorders and diseases

Medical and pharmacological research services; biological research services; medical, biological and clinical research in the field of genetic connective tissue disorders

Grant funding to medical institutions, schools, universities, colleges, educational institutions, clinical and scientific researchers; grant funding to support basic sciences, namely, genetics, molecular protein studies, molecular biology, disease models; epidemiology, therapeutics, social sciences, namely, social studies, health economics, psychology of illness; andeducation in the field of genetic connective tissue disorders; grant funding to medical research in relation to medical, biological and clinical research in the field of genetic connective tissue disorders; grant funding to medical research in relation to education, information dissemination and support services relating to medicine, pharmaceuticals, medical treatments, health, disease and genetic disorders; grant funding to medical research in relation to education, information dissemination and support services relating to genetic connective tissue disorders; charitable fund raising; charitable fundraising in relation to medical and pharmacological research; charitable fundraising in relation to medical, biological and clinical research in the field of genetic connective tissue disorders; charitable fundraising in relation to education, information dissemination and support services relating to medicine, pharmaceuticals, medical treatments, physiotherapy, health, disease and genetic disorders; charitable fundraising in relation to education, information dissemination and support services relating to genetic connective tissue disorders

Providing educational information in the academic fields of medicine, pharmaceuticals, medical treatments, health, and disease and genetic disorders for the purpose of academic study; Providing training services in the field of medicine, pharmaceuticals, medical treatments, disease and genetic disorders; conducting educational events, conferences, seminars, webinars, educational exhibitions, educational expositions, in-person educational forums, workshops, educational conventions, educational presentations, via electronic and digital media in the fields of medicine, pharmaceuticals, medical treatments, physiotherapy, health, disease and genetic disorders; publishing services in the nature of publishing journals, books, magazines, newspapers, periodicals, studies, blogs and papers in the fields of medicine, pharmaceuticals, medical treatments, health, disease and genetic disorders; publishing of electronic publications in the nature of journals, of books, magazines, newspapers, periodicals, studies, papers, blogs in the nature of online articles in the fields of medicine, pharmaceuticals, medical treatments, health, disease and genetic disorders

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 11, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 11, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2025 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 12, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 29, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 28, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 28, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 28, 2024 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 2, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 30, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 16, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 3, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 3, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 3, 2024 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 2, 2024 CRFA
ASSIGNED TO LIE
Dec 29, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 2, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 11, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 11, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 11, 2023 CNRT
ASSIGNED TO EXAMINER
May 9, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 16, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2022 NWOS
NEW APPLICATION ENTERED
Jul 27, 2022 NWAP